West Pharmaceutical Services Long Term Debt 2010-2022 | WST

West Pharmaceutical Services long term debt from 2010 to 2022. Long term debt can be defined as the sum of all long term debt fields.
  • West Pharmaceutical Services long term debt for the quarter ending June 30, 2022 was $0.208B, a 17.47% decline year-over-year.
  • West Pharmaceutical Services long term debt for 2021 was $0.209B, a 17.44% decline from 2020.
  • West Pharmaceutical Services long term debt for 2020 was $0.253B, a 0.82% decline from 2019.
  • West Pharmaceutical Services long term debt for 2019 was $0.255B, a 30.1% increase from 2018.
West Pharmaceutical Services Annual Long Term Debt
(Millions of US $)
2021 $209
2020 $253
2019 $255
2018 $196
2017 $197
2016 $226
2015 $229
2014 $308
2013 $371
2012 $379
2011 $299
2010 $358
2009 $379
West Pharmaceutical Services Quarterly Long Term Debt
(Millions of US $)
2022-06-30 $208
2022-03-31 $208
2021-12-31 $209
2021-09-30 $210
2021-06-30 $252
2021-03-31 $252
2020-12-31 $253
2020-09-30 $253
2020-06-30 $254
2020-03-31 $254
2019-12-31 $255
2019-09-30 $195
2019-06-30 $196
2019-03-31 $196
2018-12-31 $196
2018-09-30 $196
2018-06-30 $196
2018-03-31 $198
2017-12-31 $197
2017-09-30 $197
2017-06-30 $196
2017-03-31 $194
2016-12-31 $226
2016-09-30 $229
2016-06-30 $229
2016-03-31 $230
2015-12-31 $229
2015-09-30 $232
2015-06-30 $232
2015-03-31 $232
2014-12-31 $308
2014-09-30 $316
2014-06-30 $359
2014-03-31 $391
2013-12-31 $371
2013-09-30 $381
2013-06-30 $395
2013-03-31 $428
2012-12-31 $379
2012-09-30 $362
2012-06-30 $296
2012-03-31 $295
2011-12-31 $299
2011-09-30 $323
2011-06-30 $367
2011-03-31 $365
2010-12-31 $358
2010-09-30 $369
2010-06-30 $357
2010-03-31 $348
2009-12-31 $379
2009-09-30 $393
2009-06-30 $386
2009-03-31 $384
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $25.249B $2.832B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $75.203B 21.85
McKesson (MCK) United States $52.490B 15.24
AmerisourceBergen (ABC) United States $31.524B 13.92
Laboratory Of America Holdings (LH) United States $24.048B 10.52
Cardinal Health (CAH) United States $18.885B 13.70
Cooper (COO) United States $16.482B 25.37
CONMED (CNMD) United States $3.143B 30.98
Invacare (IVC) United States $0.036B 0.00